Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 22, 2018
- Accepted in final form September 19, 2018
- First Published January 9, 2019.
Article Versions
- Previous version (January 9, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Ruben P.A. van Eijk, MD, MSc,
- Henk-Jan Westeneng, MD,
- Stavros Nikolakopoulos, PhD,
- Iris E. Verhagen, MD,
- Michael A. van Es, MD, PhD,
- Marinus J.C. Eijkemans, PhD and
- Leonard H. van den Berg, MD, PhD
- Ruben P.A. van Eijk, MD, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Henk-Jan Westeneng, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stavros Nikolakopoulos, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Iris E. Verhagen, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael A. van Es, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marinus J.C. Eijkemans, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Leonard H. van den Berg, MD, PhD
Scientific Advisory Boards of Biogen, Cytokinetics, Wave Life Sciences, Freeway, Sarepta
NONE
Octapharma, Shire
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Journal of Neurology, Neurosurgery and Psychiatry Neuromuscular Disorders
NONE
NONE
NONE
NONE
NONE
received an educational grant from Shire
NONE
NONE
NONE
NONE
The Netherlands ALS Foundation; Netherlands Organisation for Health Research and Development (Vici scheme)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (R.P.A.v.E., H.-J.W., I.E.V., M.A.v.E., L.H.v.d.B.), Brain Center Rudolf Magnus, and Biostatistics & Research Support (R.P.A.v.E., S.N., M.J.C.E.), Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands.
- Correspondence
Dr. van den Berg lberg{at}umcutrecht.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALSP. H. Gordon, B. Cheng, I. B. Katz et al.Neurology, June 01, 2009 -
Article
The PRO-ACT databaseDesign, initial analyses, and predictive featuresNazem Atassi, James Berry, Amy Shui et al.Neurology, October 08, 2014 -
Articles
ALS clinical trialsDo enrolled patients accurately represent the ALS population?A. Chiò, A. Canosa, S. Gallo et al.Neurology, September 28, 2011 -
Contemporary Issues in Practice, Education, & Research
Innovating Clinical Trials for Amyotrophic Lateral SclerosisChallenging the Established OrderRuben P.A. van Eijk, Stavros Nikolakopoulos, Kit C.B. Roes et al.Neurology, July 27, 2021